Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity

Details for Australian Patent Application No. 2007227425 (hide)

Owner Schering Corporation PHARMACOPEIA, INC.

Inventors McGuinness, Brain F.; Hobbs, Douglas W.; Shih, Neng-Yang; Rosenblum, Stuart B.; Kozlowski, Joseph A.

Agent Griffith Hack

Pub. Number AU-A-2007227425

PCT Pub. Number WO2007/109238

Priority 60/784,504 21.03.06 US

Filing date 19 March 2007

Wipo publication date 27 September 2007

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/497 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/109238 Priority application(s): WO2007/109238

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007227432-Treatment of tissue volume with radiant energy

2007227423-Microrna fingerprints during human megakaryocytopoiesis